| Ytd | 0.52% | |
| 1y | -14.47% |
| Open | 28.78 | Prev Close | 29.08 | Low | 28.78 | High | 29.08 | Mkt Cap | 189.01M |
| Vol | 624.03K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -2.19 |
| Beta | 0.44 | Short Ratio | 6.45 | Inst. Own | 95.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 6.50 |
MRSN News
Cwm LLC lowered its position in shares of Mersana Therapeutics, Inc. (NASDAQ: MRSN) by 96.5% in the
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
BALA CYNWYD, Pa. , Dec. 23, 2025 (GLOBE NEWSWIRE) -- Brodsky and Smith reminds investors of the foll
MILWAUKEE , Dec. 16, 2025 /PRNewswire/ -- The Ademi Firm continues to investigate Mersana (NASDAQ: M
NEW YORK and NEW ORLEANS , Dec. 12, 2025 /PRNewswire/ -- Former Attorney General of Louisiana Charle
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is invest
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, Nov. 27, 2025 (GLOBE NEWSWIRE) -- We wish you a Happy Thanksgiving and Class Action Attorn
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Mersana Therapeutics, Inc. (MRSN) came out with a quarterly loss of $1.51 per share versus the Zacks
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde an
Mersana Therapeutics, Inc. ( MRSN ) M&A Call November 13, 2025 8:00 AM EST Company Participants Joey
MILWAUKEE , Nov. 13, 2025 /PRNewswire/ -- The Ademi Firm is investigating Mersana (NASDAQ: MRSN) for
Day One Biopharmaceuticals (NASDAQ: DAWN) on Thursday agreed to acquire Mersana Therapeutics Inc. (N
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in
CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a cli
The average of price targets set by Wall Street analysts indicates a potential upside of 248.8% in M
Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM E
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourt
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance f
Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the co
Gainers
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar